AIDS and sexually transmitted diseases | Country profiles | Libya HIV country profile 2016

Libya HIV country profile 2016

Print PDF

Sociodemographic data

  • Total population (in millions): 6.3
  • Maternal mortality per 100 000 live births :9
  • Life expectancy at birth (years) : 72
  • Total fertility rate (births per woman) : 2.5
  • GNI per capita, PPP (current international US$) 
  • Health expenditure, total (% of GDP) : 5.0
  • Health expenditure per capita (current US$) : 372
  • Human Development Index Value : 0.72
HIV care cascade and progress towards 90-90-90

Libya_fig_1

Epidemiological data (2016)

HIV estimates and case notification

 

Estimated

Reported

HIV prevalence in general population

NA

People living with HIV (PLHIV)

NA

New infections

NA 309

AIDS-related deaths

NA 121

 

 

 

Libya_fig_2

Estimated.reported

HIV in specific populations

 

Survey data

 

Size estimate

Routine testing and VCT data

Key populations

Prevalence

 

 

No tested

HIV+ cases (%)

Sex workers (SW)

 

No data

Men having sex with men (MSM)

 

No data

People who inject drugs (PWIDs)

 

       No data


Prisoners

 

       No data         

Populations in health settings

 

 

 

 No data

 

TB patients

 

 

 

No data

Pregnant women

 

 

 

No data

Blood donors

 

 

 

No data

Clients of testing services

 

 

 

No data

Response

Policy implementation

 

 

Implementation of national policy on HIV self-testing (HIVST)

Policy on HIVST but still not implemented

Treatment initiation threshold adults and adolescents

Treat All regardless of CD4 count

Implementation of Treat All adults and adolescents

Implemented in few (<50%) treatment sites

Treatment initiation threshold children

Treat All regardless of age

Implementation of lifelong ART to pregnant & breastfeeding women 

Implemented in a small number (<50%) of MCH sites

Implementation of national policy on viral load monitoring

Fully implemented

HIV testing coverage in key populations *

Data not available

Antiretroviral therapy and PMTCT coverage

Libya_fig_3

References 

(1) http://www.prb.org/pdf16/prb-wpds2016-web-2016.pdf; (2) WHO.EMRO Regional Surveillance Data; (3) UNAIDS/WHO estimates 2016; (4) Global AIDS Monitoring (GAM) 2016.